PhillyPharma Archive: April, 2013

Further Pfizer spin-offs still somewhere in the future

Comment icon 0 Comments
Drugmaker Pfizer said Tuesday it might be years before the company separates its "innovative" products division from its more established products... Read more

Pfizer revenue falls 9 percent, but net income rises with help from sale of Chinese joint venture

Comment icon 0 Comments
Drugmaker Pfizer reported that generic competition was a key factor its a 9 percent decline in worldwide sales revenue in the first quarter... Read more

AstraZeneca earnings per share declined 31 percent in first quarter

Comment icon 0 Comments
Drugmaker AstraZeneca said Thursday that its first quarter profits fell 31 percent, as measured by earnings per share, from the same period... Read more

With Supreme Court weighing a case, GSK's Andrew Witty says 'pay-to-delay' label misleading, defends such settlements

Comment icon 0 Comments
As drugmaker GlaxoSmithKline reported 25 percent lower, after-tax profits in the first quarter of 2013 compared to a year earlier, chief executive... Read more

As quarterly profit falls 25.1 percent, GlaxoSmithKline to separate "legacy" products, perhaps for future sale

Comment icon 0 Comments
As drugmaker GlaxoSmithKline reported 25.1 percent lower after-tax profit in the first quarter of 2013 compared to a year earlier, chief executive... Read more

GlaxoSmithKline first-quarter global sales were down 2 percent from a year ago

Comment icon 0 Comments
London-based drugmaker GlaxoSmithKline issued its first quarter financial report Wednesday morning. GSK has facilities in the Philadelphia... Read more

E&Y biotech report says start-ups have to quickly catch-up to reality

Comment icon 0 Comments
Ernst & Young issued its yearly report on the biotechnology industry and one key takeaway is that young companies need to more quickly... Read more

Four senators push bill to improve medicine tracking in pharmaceutical supply chain

Comment icon 0 Comments
It might shock many patients that this doesn't already exist, but four U.S. senators are pushing a bill that would eventually require every... Read more